Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
CNY 64.67
(-0.06%)
CNY 64.67
(-0.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 149.24 Million CNY | -92.25% |
| 2022 | 3.35 Billion CNY | 70.94% |
| 2021 | 1.96 Billion CNY | 45.4% |
| 2020 | 1.34 Billion CNY | 471.69% |
| 2019 | 236.11 Million CNY | 25.31% |
| 2018 | 188.41 Million CNY | 21.69% |
| 2017 | 154.83 Million CNY | 46.79% |
| 2016 | 105.48 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 55.13 Million CNY | -2.02% |
| 2024 Q2 | 56.26 Million CNY | -12.94% |
| 2024 Q1 | 64.62 Million CNY | -31.1% |
| 2023 FY | 260.01 Million CNY | -92.25% |
| 2023 Q1 | 61.32 Million CNY | -91.83% |
| 2023 Q2 | 59.48 Million CNY | -3.0% |
| 2023 Q4 | 93.8 Million CNY | 106.64% |
| 2023 Q3 | 45.39 Million CNY | -23.69% |
| 2022 Q4 | 750.38 Million CNY | 18.7% |
| 2022 Q3 | 632.18 Million CNY | -36.83% |
| 2022 Q2 | 1 Billion CNY | 3.01% |
| 2022 FY | 3.35 Billion CNY | 70.94% |
| 2022 Q1 | 971.55 Million CNY | 141.13% |
| 2021 Q3 | 726.08 Million CNY | 257.43% |
| 2021 Q1 | 630.54 Million CNY | 38.05% |
| 2021 FY | 1.96 Billion CNY | 45.4% |
| 2021 Q4 | 402.91 Million CNY | -44.51% |
| 2021 Q2 | 203.14 Million CNY | -67.78% |
| 2020 Q3 | 411.76 Million CNY | 35.12% |
| 2020 Q2 | 304.75 Million CNY | 72.61% |
| 2020 Q1 | 176.55 Million CNY | 121.85% |
| 2020 FY | 1.34 Billion CNY | 471.69% |
| 2020 Q4 | 456.75 Million CNY | 10.92% |
| 2019 FY | 236.11 Million CNY | 25.31% |
| 2019 Q4 | 79.57 Million CNY | 41.26% |
| 2019 Q3 | 56.33 Million CNY | -2.03% |
| 2019 Q1 | 42.68 Million CNY | -28.01% |
| 2019 Q2 | 57.5 Million CNY | 34.71% |
| 2018 Q4 | 59.3 Million CNY | -3.54% |
| 2018 FY | 188.41 Million CNY | 21.69% |
| 2018 Q3 | 61.47 Million CNY | 0.0% |
| 2017 FY | 154.83 Million CNY | 46.79% |
| 2016 FY | 105.48 Million CNY | 0.0% |